A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
Fire service confirms that two buildings have collapsed in an explosion thought to have been caused by a gas leak.
Famous global landmarks fell dark for 60 minutes to mark Earth Hour, a campaign urging awareness and action on climate change.
Police have shut off part of the famous Las Vegas Strip after a gun man barricaded himself inside a bus after killing at least one.